Clinical Trial Update: A Trial to Reduce Hepatitis C Among Injection Drug Users - 1 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial aimed at reducing hepatitis C infection among injection drug users has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Butler Hospital | Conditions: HCV Negative Status, HCV Risk Behavior | Phase 3 | Status: COMPLETED